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Background and objectives: Infectious pathogens in blood are a potential source of transmission
of hepatitis B and C, human immunodeficiency virus (HIV) and syphilis. The present study reviews
the frequency of these infections in volunteer and replacement blood donors in Lahore, Pakistan.
Methods: Data on serologic testing of blood donors (using commercial assays) were reviewed for
the years 1996—2005. Data from 2004 and 2005 were also analyzed with respect to age and type of
donor (volunteer versus replacement).
Results: The frequency of serologic evidence of various infectious pathogens ranged as follows:
hepatitis B 1.46—2.99%, with a downward trend over time, hepatitis C 3.01—4.99%, HIV 0—0.06%,
and syphilis 0.19—0.57%. Amongst replacement donors, younger individuals (<35 years) had lower
seroprevalence of hepatitis markers as compared to older persons. Overall, volunteer donors
(6.98% of all donors) had the lowest seroprevalence for the diseases.
Conclusions: The frequency of hepatitis C amongst Pakistani donors is the highest in the region
while that of hepatitis B is declining gradually. Volunteer donors have lower frequencies of tested
infections compared to replacement donors. Compared to neighboring India, syphilis occurs with
a similar frequency but HIV is seen less commonly.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
There are approximately 1.5 million transfusions every
year in Pakistan.1 Blood component transfusion is a poten-
tially important source for the transmission of blood-borne
infections. Careful selection and screening of blood donors
are crucial strategies to reduce this risk. Data from screen-* Corresponding author. Tel.: +92 42 5945100; fax: +92 42 5945205.
E-mail address: faisal@skm.org.pk (F. Sultan).
1201-9712/$32.00 # 2006 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2006.10.004ing may serve as an important source of information
about prevalence of various infectious pathogens in the
blood donor population and to some extent in the general
population.
We undertook a review of the frequency of serologic
evidence of hepatitis B (HBV), hepatitis C (HCV), human
immunodeficiency virus (HIV) and syphilis over a ten-
year period. Data from our institution of over 40 000
donors over a ten-year time span present a unique oppor-
tunity to evaluate trends in frequency of these diseases in
Lahore.Published by Elsevier Ltd. All rights reserved.
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Setting
This study was undertaken at a tertiary care cancer center
in Lahore with a referral base from all over Pakistan but
predominantly from the Punjab and the North West Frontier
Province (NWFP).
Donor population
All donors were either healthy volunteers or family or friends
(replacement donors) of the patient. All donors were inter-
viewed prior to donation and excluded if they were under 18
years of age or over 55 years of age, or if they had a
hemoglobin <12 g/dl. High-risk donors were excluded via a
standard questionnaire focused on obtaining a history of
jaundice as well as a history of high-risk behavior for acquisi-
tion of sexual and blood-borne infections.
Testing
Over the ten-year review period, a number of different
commercial methods were used for the detection of patho-
gens and manufacturer’s instructions were followed.
Detection of hepatitis B surface antigen (HBsAg) was
carried out using NovaPath HBsAg EIA (Bio-Rad Laboratories
Inc., Hercules, CA, USA) until 2001 and a microparticle
enzyme immunoassay (MEIA) — AxSYM HBsAg (V2) (Abbott
Diagnostics Division, Wiesbaden, Germany) — from 2001 until
2005. Urgent testing when required was carried out using IMX
HBsAg (V2) (Abbott Diagnostics Division, Abbott Park, IL,
USA).
Detection of anti-HCV antibodies was carried out using
NovaPath HCV EIA (Bio-Rad Laboratories Inc., Hercules, CA,
USA) until 2001 and MEIA AxSYM HCV version 3.0 (Abbott
Diagnostics Division, Wiesbaden, Germany) from 2001 until
2005. Urgent testing when required was done using IMX HCV
version 3.0 (Abbott Diagnostics Division, Abbott Park, IL,
USA).Table 1 Frequency of positive tests for HBsAg, anti-HCV, anti-HIV
Hospital and Research Centre, Lahore, Pakistan for the years 1996
Time period Total screened HBsAg positive Ant
Number % Num
1996 3152 68 2.16 11
1997 4356 124 2.85 15
1998 3609 108 2.99a 12
1999 2825 76 2.69 14
2000 2442 68 2.78 9
2001 3525 91 2.58 10
2002 3882 96 2.47 16
2003 3819 74 1.94 14
2004 7170 105 1.46 24
2005 6718 111 1.65 23
Total 41 498 921 2.22 152
a From 1998 to 2005: x2 for linear trend = 44.707445, p < 0.0001.
b From 1999 to 2005: x2 for linear trend = 8.170637, p = 0.0043.HIV-1 and -2 detection was done using IMX HIV-1/HIV-2 III
Plus (Abbott Diagnostics, Wiesbaden, Germany) and AxSYM
HIV 1/2 gO (Abbott Diagnostics Division, Wiesbaden, Ger-
many).
Testing for syphilis was done via Immutrep RPR (Omega
Diagnostics Limited, Alva, Scotland, UK), which is a qualita-
tive card flocculation test utilizing cardiolipin antibody. Since
the testing was done for screening purposes, a confirmatory
treponemal test (e.g. fluorescent treponemal antibody
absorption test (FTA-ABS) or Treponema pallidum hemagglu-
tination assay (TPHA)) was not done.
Data collection
Hospital blood bank records were reviewed to gather data on
total numbers of specimens tested and those reported posi-
tive for HBsAg, anti-HCV, anti-HIV-1 and -2, and RPR (rapid
plasma reagin). For the years 1996—2000, paper records were
reviewed; for 2001—2005, the hospital’s electronic hospital
record was accessed. All donors tested in the study period
were included in the analysis.
Statistical analysis
Significance of frequency variation over time was assessed by
using the 2 by k x2 test for linear trends as described by
Armitage and Berry2 using StatsDirect1 statistical software
(available at http://www.statsdirect.com and StatsDirect
Ltd, Cheshire, UK).
Results
The frequencies (by year) of positive tests for the study
period are summarized in Table 1 and shown in graphical
form in Figure 1. A total of 41 498 donors were tested. A
positive HBsAg was found in 921 (2.22%) and this frequency
has shown a statistically significant decline (x2 for linear
trend = 44.707445, p < 0.0001) since 1998 when a peak of
2.99% was seen. Antibodies to HCV were found in 1529
(3.68%) donors and a statistically significant decline from aand RPR in blood donors at Shaukat Khanum Memorial Cancer
—2005
i-HCV positive HIV positive RPR positive
ber % Number % Number %
2 3.55 1 0.03 6 0.19
2 3.48 0 0.00 14 0.32
6 3.49 0 0.00 16 0.44
1 4.99b 0 0.00 11 0.39
9 4.05 1 0.04 13 0.53
6 3.01 1 0.03 18 0.51
7 4.30 0 0.00 22 0.57
2 3.72 0 0.00 17 0.45
9 3.47 4 0.06 31 0.43
5 3.50 4 0.06 32 0.48
9 3.68 11 0.03 180 0.43
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Figure 1 Frequency of positive tests for infectious pathogens
in blood donors at Shaukat KhanumMemorial Cancer Hospital and
Research Centre, Lahore, Pakistan (1996—2005).peak of 4.99% in 1999 was seen (x2 for linear
trend = 8.170637, p = 0.0043). Eleven donors (0.03%) were
anti-HIV positive by ELISA. A positive serologic test for syphi-
lis was found in 180 (0.43%).
Table 2 shows the frequency of positive tests amongst
three subsets within our study from the years 2004 and 2005:
(a) volunteer donors under the age of 35 years (n = 970,
6.98%); (b) replacement donors under the age of 35 years
(n = 11 396, 82.06%); (c) replacement donors aged between
35 and 55 years (n = 1522, 10.96%). Themean age of donors in
this group was 35 years with a median of 33 years.
Discussion
Published data on the frequency of various blood-borne
infections amongst blood donors in Pakistan are summarized
in Table 3.3—14 Table 3 also lists the frequencies amongst
three groups within our study (volunteers aged <35 years,
replacement donors<35 years, and replacement donors aged
35—55 years) for the years 2004 and 2005. Table 4 provides a
summary of selected reports from the region showing the
frequency of infectious pathogens in blood donors.15—20
The decline in the frequency of HBsAg seen in our data has
also been reported from other countries in the region.7,16
This may in part be due to improved awareness and increased
vaccination against hepatitis B in the country during the same
period. Although from different institutions, the rates of
hepatitis B vaccination coverage amongst healthcare workers
(49% in 2000 to 98% in 2003) have improved over time.21,22
The seroprevalence of hepatitis B was similar amongst
volunteer and replacement donors who were under 35 yearsTable 2 Frequency of positive tests for HBsAg, anti-HCV, anti-HIV





Volunteers (all <35 years) 970 14 1.4
Replacement donors (<35 years) 11 396 161 1.4
Replacement donors (35—55 years) 1522 41 2.6of age but was higher amongst replacement donors who were
35—55 years of age. This is especially noteworthy due to the
differences in rates in the <35 years age group seen for HCV
(as below). It is tempting to ascribe the similarity of rates
amongst volunteer and replacement donors and the differ-
ence with older replacement donors to better vaccination
rates against hepatitis B in younger donors. Research on the
epidemiology of acquisition of hepatitis in Pakistan is
required to answer this question. Reported seroprevalence
rates over the last decade from the region have been lower
compared to ours and are reported in Table 4.
The frequency of anti-HCV positive donors remained at
between 3% and 5% during the period of study. This figure
is similar to reported figures for the Pakistani population.5—
8,10,12—14 The seroprevalence for HCV was lowest amongst
volunteer donors (all under 35 years of age) and was lower
than in replacement donors of the same age group. This fact
is of importance in terms of policy since some of the differ-
ence may be due to differences in health behavior and
attitudes of volunteer donors versus replacement donors,
but may also reflect the possibility that some of the replace-
ment donors may be paid donors brought in by family mem-
bers to masquerade as replacement/family donors. Improved
health provider and public education awareness as well as
the crossover effect of hepatitis B vaccination campaigns on
awareness or HIV/AIDS awareness campaigns are possible
explanations for the apparent declining trend noted in our
study. Reported seroprevalence rates over the last decade
from the region are presented in Table 4. Pakistan has a larger
problem in terms of hepatitis C compared to its eastern and
western neighbors (India and Iran) as well as others in the
region (Saudi Arabia and Turkey).
To our knowledge, no other large study has reported
seroprevalence for syphilis in Pakistan. None of the volunteer
donors tested in the years 2004—2005 in our group had a
positive serology for syphilis while replacement donors had
frequencies of 0.50% (those aged<35 years) and 0.39% (those
aged 35—55 years). The frequency of individuals in our study
with a positive RPR or VDRL remained between 0.19% and
0.57%, similar to the Indian figures as shown in Table 4.
Pakistan has recently been reclassified as a country with
concentrated epidemic in high-risk groups for HIV by
UNAIDS23. The number of individuals living with HIV is esti-
mated to be 85 000 by UNAIDS and the adult (age 15—49
years) HIV prevalence rate is estimated to be 0.1% (range
0.1—0.2%). Population estimates are based on known or
reported seroprevalence amongst various risk groups (includ-
ing the general population) and extrapolation of this data to
the overall population using available information about the
size of various groups in the population. Blood donors, on the
other hand, are a selected population — both via screeningand RPR in three different groups of blood donors at Shaukat
akistan for the years 2004—2005
Anti-HCV positive HIV positive RPR positive
Number % Number % Number %
4 12 1.24 0 0 0 0
1 376 3.30 3 0.03 57 0.50
9 96 6.31 5 0.33 6 0.39
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Kayani 3 1986—1992 Karachi Blood donors 32 127 NR NR 0.009 (0.003)b NR
Mujeeb4 1987—1989 Karachi Blood donors 1655 NR NR 0 NR
Mujeeb5 1995 Karachi Family donors 839 4.9 2.4 0 NR
Kakepoto6 1996 Karachi Volunteers 16 705 NR 1.18 NR NR
Bashawri 7 1998—2001 Pakistanis in
Saudi Arabia
Volunteers 217 3.85 3.85 0 NR
Akhtar8 1998—2002 Karachi Volunteers 351 309 NR 1.8 NR NR
Sheikh9 1999 Balochistan Volunteer male
donors
5000 NR NR 0.96 (0.22) c NR
Abdul Mujeeb10 2000 Karachi Volunteers 612 2.21 3.0 0 NR
Rahman11 2000 Lahore Volunteer donors 8161d NR NR NR 0.78
Asif 12 2002—2003 Islamabad Volunteers 243 0.82 2.46 0 NR
Replacement/
family donorse
3187 2.51 5.14 0.25 NR
Ali 13 2003 Quetta Volunteers 1635 NR 1.87 NR NR
Khokhar14 1998—2004 Islamabad Volunteer male
donors
47 538 2.56 5.31 NR NR
Present study 1996—2005 Lahore Volunteer and
replacement
donors
41 498 2.21 3.68 0.02 0.43
2004—2005 Volunteers
<35 years








1522 2.69 6.30 0.32 0.39
NR, not reported.
a Percent positive via confirmatory test.
b One of three positive by ELISA were confirmed positive by western blot.
c Of 48 individuals positive by rapid testing, 11 were positive by ELISA.
d Randomly chosen out of 62 090 donors from June to September 2000. Treponema pallidum hemagglutination assay (TPHA) used to screen
donors.
e Felt to include paid donors presented as relatives or friends by family.questionnaires and the disproportionate number of younger
individuals in the group. Thus HIV was seen with lower
frequency in our donor population (0.03%) compared to
national estimates. Higher numbers (0.33%) were seen in
replacement donors who were older than 35 years. How
many of these were false positives is not known since the
results of confirmatory testing by the donors’ own physicians
were not available to us. The issue of false positives by ELISA
(of up to 66%3) is especially relevant in a low prevalence
population with the consequential psychological and emo-
tional burden on the persons affected. Sheikh et al. reported
a false positive rate of 77% when a rapid test (Capillus HIV-1/
HIV-2, Cambridge Diagnostics, Ireland) was used to screen for
HIV in blood donors.9 Knowledge of this aspect of HIV screen-
ing is crucial amongst personnel reporting screening test
results to donors.
The national estimate for HIV prevalence in Pakistan is
also much lower compared to neighboring India where it is
estimated to range from 0.4% to 1.3%.23 This is reflected in
donor data from India as well; however, wide ranges havebeen reported in blood donor populations from various Indian
institutions (Table 4).
A randomized controlled trial in South Africa suggested
protection against acquisition of HIV of up to 61% from
circumcision,24 but cost-effectiveness and acceptance are
yet to be demonstrated.25 Protection against syphilis may
also be afforded by circumcision as suggested in a recent
meta-analysis, but heterogeneity was noted amongst stu-
dies, suggesting the effect of other variables.26 This dis-
concordance in prevalence of HIV (but not syphilis) in
neighboring countries is intriguing. While the practice of
male circumcision in predominantly Muslim Pakistan may
play a role, other socio-cultural and biological factors are
likely to be operative as well. Societal attitudes towards sex
as well as relatively more overt commercial sex activity in
India may play a role in the difference in HIV prevalence
rates, but the concurrent similarity of frequency of syphilis
remains a question perhaps best answered by additional
research into transmission of HIV and syphilis in the Indian
subcontinent.
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Volunteers 4666 2.57 a 0.279 0.22
Replacement 42 291 3.52 0.328 0.461 0.239
Sharma16 1996—2002 Chandigarh,
India
Blood donors 235 461b 1.55 to 0.99c 0.4 0.16 to 0.3c 0.11 to 0.66c
Singh17 1997—1999 Delhi, India Volunteer and
replacement
52 500 1.8 0.5 0.8 2.76
Gupta18 2001—2003 Ludhiana,
India
Volunteer 44 064 0.66 1.09 0.084 0.85
Bashawri 7 1998—2001 Saudi Arabia Volunteers 10 778 2.34 0.98 0 NR
Ghavanini 19 2000 Iran Volunteer 7897 1.07 0.59 NR NR
Mutlu20 1999—2004 Turkey Volunteer 29 049 2.3 0.37 0d 0.02




41 498 2.21 3.68 0.02 0.43
2004—2005 Volunteers
<35 years
970 1.44 1.23 0 0
Replacement
<35 years
11 396 1.41 3.29 0.02 0.50
Replacement
35—55 years
1522 2.69 6.30 0.32 0.39
NR, not reported.
a Only replacement donor data provided for anti-HCV by authors.
b Proportion of voluntary donors increased from 47% to 56% in study period.
c Rates at beginning and end of study period.
d Eight individuals reported positive by ELISA (0.03% of total) but all had negative western blot tests.Blood transfusions remain an important vehicle for trans-
mission of infectious pathogens. Legislation to regulate blood
transfusion has been passed at provincial and federal levels in
Pakistan,27,28 but enforcement remains a major challenge.
The higher risk amongst replacement donors identified in our
study is similar to other reports from the region12,15 and re-
emphasizes the need for increasing the numbers of transfu-
sions via volunteers and avoidance of replacement and family
donors.
Continued education of the public and healthcare profes-
sionals will play an important part in control of this problem
since injections in the healthcare setting in Pakistan are
reported as a risk factor for acquisition of hepatitis B and
C in adults as well as children.29—33 Shaving of beards and
armpits by barbers has also been identified as a risk for
hepatitis C by Bari et al.,32 providing another avenue of
public health intervention for risk reduction.
Enhanced coverage of the population with vaccination
against hepatitis B via vaccination drives is likely to further
reduce rates amongst donors. Pakistan received a grant
(2001—2002) from the Global Alliance for Vaccines and
Immunization (GAVI) towards inclusion of hepatitis B vacci-
nation in the Expanded Program on Immunization (EPI),
which aims to cover all Pakistani children — something that
will drive further reduction in seroprevalence in the
long-term.34
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